Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) clinical trial (NCT00386425). Contact the study team or your healthcare provider for specific answers.

Question 2

How does drotrecogin alfa (activated) compare to other treatments I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) clinical trial (NCT00386425). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) clinical trial (NCT00386425). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) clinical trial (NCT00386425). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) clinical trial (NCT00386425). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) clinical trial (NCT00386425). Contact the study team or your healthcare provider for specific answers.

What this study is about